Skip to main content
Quanta Report
HealthNorway

Norwegian Crown Princess Mette‑Marit's Lung Transplant Triumph

The 52‑year‑old royal undergoes a successful transplant amid legal and personal turbulence.

Source: bbc.co.uk1 min read
Norwegian Crown Princess Mette‑Marit's Lung Transplant Triumph
Image via bbc.co.uk

In brief

Princess Mette‑Marit, diagnosed with pulmonary fibrosis in 2018, now returns to the public eye after a successful lung transplant in Oslo. The operation comes as her son Marius faces a four‑year prison sentence and reflects a rift in the royal family. Experts emphasize the delicate postoperative period and lifelong immunosuppression needed for transplant survivors, while the royal household adjusts schedules to support her recovery. The transplant marks the latest challenge in an otherwise turbulent year for Norway's monarchy.

In Oslo, Crown Princess Mette‑Marit underwent a successful lung transplant, the royal household announced, marking a significant milestone in her medical journey.

Diagnosed with a rare form of pulmonary fibrosis in 2018, her condition had worsened in recent months, prompting the decision to transplant her deteriorating lungs.

Lung specialist Are Holm praised the surgery’s outcome, noting that Mette‑Marit will remain in hospital for several weeks under close observation—a standard protocol for transplant recipients.

The operation was followed two days after her son, Marius Borg Høiby, was sentenced to four years in prison on charges of rape. Høiby, who is not a royal official but the son of the Crown Princess, has defended himself against the most serious allegations while announcing an appeal.

Prince Haakon adjusted his official schedule to support his wife’s recovery, a gesture highlighted by the palace as a sign of unity amid the family’s public scrutiny. Historian Ole‑Jørgen Schulsrud‑Hansen applauded the transplant as “very happy news” for the Norwegian monarchy.

Holm cautioned that transplant survivors must navigate a delicate postoperative period, with lifelong immunosuppressive medication and a risk that one‑in‑eight patients do not survive the first year. About fifty percent of recipients are reportedly alive after ten years.

The transplant comes amid prior controversies: the Crown Princess admitted a decades‑old friendship with the late Jeffrey Epstein and expressed regret, and documents surfaced in January revealing frequent contact with the disgraced sex offender.

For those interested, the Crown Princess’s last public appearance was on 17 May, where she required a nasal tube connected to an oxygen device. A separate link provides details of her release onto the transplant list: transplant list details.

This medical triumph underscores significant advances in transplant medicine and the continued grave responsibility of life‑supporting treatment, as the Norwegian royal family shifts toward a hopeful future.

Topics

More on this story